Clinical Trials
317
Active:8
Completed:89
Trial Phases
6 Phases
Early Phase 1:5
Phase 1:15
Phase 2:17
+3 more phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (207 trials with phase data)• Click on a phase to view related trials
Not Applicable
147 (71.0%)Phase 2
17 (8.2%)Phase 1
15 (7.2%)Phase 4
14 (6.8%)Phase 3
9 (4.3%)Early Phase 1
5 (2.4%)RIRS With Flex Suction Sheath vs. PCNL for 2-3 cm Renal Stones
Not Applicable
Recruiting
- Conditions
- Nephrolithiasis
- First Posted Date
- 2025-07-10
- Last Posted Date
- 2025-07-10
- Lead Sponsor
- Changhai Hospital
- Target Recruit Count
- 308
- Registration Number
- NCT07058402
- Locations
- 🇨🇳
Changhai Hospital, Naval Medical University, Shanghai, Shanghai, China
Evaluate the Efficacy and Safety of Probiotic 6600 as an Adjuvant Therapy for Colitis
Not Applicable
Recruiting
- Conditions
- IBD (Inflammatory Bowel Disease)ColitisProbiotic Intervention
- Interventions
- Drug: PlaceboDrug: Probiotics 6600
- First Posted Date
- 2025-07-02
- Last Posted Date
- 2025-07-02
- Lead Sponsor
- Changhai Hospital
- Target Recruit Count
- 120
- Registration Number
- NCT07047339
- Locations
- 🇨🇳
Changhai Hospital, Shanghai, China
Prediction Model of Pancreatic Neoplasms in CP Patients With Focal Pancreatic Lesions
Not yet recruiting
- Conditions
- Machine LearningChronic PancreatitisPancreatic Neoplasm
- First Posted Date
- 2025-07-01
- Last Posted Date
- 2025-07-01
- Lead Sponsor
- Changhai Hospital
- Target Recruit Count
- 106
- Registration Number
- NCT07045181
- Locations
- 🇨🇳
Changhai Hospital, Shanghai, Shanghai, China
Clinical Trial of PCSK9 Inhibitor and Statin Treatment for Carotid Artery Stenosis
Phase 4
Not yet recruiting
- Conditions
- Carotid Artery Stenosis
- Interventions
- Drug: Evolocumab (biweekly injections) + Rosuvastatin/Atorvastatin ± EzetimibeDrug: Rosuvastatin/Atorvastatin ± Ezetimibe
- First Posted Date
- 2025-06-25
- Last Posted Date
- 2025-06-25
- Lead Sponsor
- Changhai Hospital
- Target Recruit Count
- 406
- Registration Number
- NCT07036991
The 22G Trident Needle Combined With Different Aspiration Techniques for Endoscopic Ultrasound-guided Fine-needle Biopsy
Not Applicable
Not yet recruiting
- Conditions
- Pancreatic Diseases
- First Posted Date
- 2025-06-17
- Last Posted Date
- 2025-06-17
- Lead Sponsor
- Changhai Hospital
- Target Recruit Count
- 270
- Registration Number
- NCT07023562
- Locations
- 🇨🇳
Changhai Hospital, Shanghai, Shanghai, China
- Prev
- 1
- 2
- 3
- 4
- 5
- 62
- Next
News
PROTECT-MT Trial Suggests Worse Outcomes with Balloon Guide Catheters in Stroke Thrombectomy
The PROTECT-MT trial, a randomized controlled study, indicated that stroke thrombectomy using balloon guide catheters (BGCs) may lead to inferior functional outcomes compared to conventional guide catheters.